ES2060610T3 - Nuevos derivados del cannabinol e inmunoensayo perfeccionado. - Google Patents

Nuevos derivados del cannabinol e inmunoensayo perfeccionado.

Info

Publication number
ES2060610T3
ES2060610T3 ES88100732T ES88100732T ES2060610T3 ES 2060610 T3 ES2060610 T3 ES 2060610T3 ES 88100732 T ES88100732 T ES 88100732T ES 88100732 T ES88100732 T ES 88100732T ES 2060610 T3 ES2060610 T3 ES 2060610T3
Authority
ES
Spain
Prior art keywords
derivative
canabinol
cannabinol
perfected
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88100732T
Other languages
English (en)
Spanish (es)
Inventor
Alan Joseph Mcnally
Alan Schwartz
Magdalena Usategui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2060610T3 publication Critical patent/ES2060610T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES88100732T 1987-01-27 1988-01-20 Nuevos derivados del cannabinol e inmunoensayo perfeccionado. Expired - Lifetime ES2060610T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/007,838 US4833073A (en) 1987-01-27 1987-01-27 Immunoassay for tetrahydrocannabinol metabolites

Publications (1)

Publication Number Publication Date
ES2060610T3 true ES2060610T3 (es) 1994-12-01

Family

ID=21728380

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88100732T Expired - Lifetime ES2060610T3 (es) 1987-01-27 1988-01-20 Nuevos derivados del cannabinol e inmunoensayo perfeccionado.

Country Status (12)

Country Link
US (1) US4833073A (de)
EP (1) EP0276732B1 (de)
JP (1) JPH0819117B2 (de)
AT (1) ATE97895T1 (de)
AU (1) AU614733B2 (de)
DE (1) DE3885911T2 (de)
DK (1) DK37888A (de)
ES (1) ES2060610T3 (de)
FI (1) FI96685C (de)
HK (1) HK63595A (de)
NO (1) NO171274C (de)
NZ (1) NZ223289A (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264373A (en) * 1987-02-17 1993-11-23 Abbott Laboratories Fluorescence polarization immunoassay for tetrahydrocannabinoids
EP0392332A3 (de) * 1989-04-12 1992-01-08 F. Hoffmann-La Roche Ag Fluoreszenzpolarisationsimmunoassay und Reagentien dafür
US5001743A (en) * 1990-01-10 1991-03-19 Northern Telecom Limited Method and apparatus for controlling a telephone answering device
IL99468A (en) * 1991-09-12 1997-09-30 Yissum Res Dev Co (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
US5292899A (en) * 1991-11-27 1994-03-08 Synthetic Technology Corporation Synthesis of 11-nor-Δ-9-tetrahydrocannabinol-9-carboxylic acid glucuronide
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5315015A (en) * 1992-11-10 1994-05-24 Hoffmann-La Roche Inc. Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same
US5817766A (en) * 1995-04-05 1998-10-06 Roche Diagnostic Systems, Inc. Reagents for a cannabinoid immunoassay
US6162829A (en) * 1997-10-17 2000-12-19 Atlantic Pharmaceuticals, Inc. (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US6248598B1 (en) 1998-09-17 2001-06-19 Stuart C. Bogema Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
AU3910700A (en) 1999-03-22 2000-10-09 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US8084467B2 (en) 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7741365B2 (en) 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US7393842B2 (en) 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
CA2387764A1 (en) 1999-10-18 2001-04-26 University Of Connecticut Peripheral cannabinoid receptor (cb2) selective ligands
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
EP1361876A4 (de) 2001-01-26 2004-03-31 Univ Connecticut Neue cannabimimetische liganden
DE60237431D1 (de) 2001-01-29 2010-10-07 Univ Connecticut Rezeptor-selektive cannabimimetische aminoalkylindole
JP4312594B2 (ja) 2001-07-13 2009-08-12 ユニバーシティ オブ コネチカット 新規な二環式及び三環式カンナビノイド
US7666867B2 (en) 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2003265663A1 (en) * 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
US8288544B2 (en) 2003-07-01 2012-10-16 Roche Diagnostics Operations, Inc. Electrochemical affinity biosensor system and methods
US20060051824A1 (en) * 2004-09-03 2006-03-09 Haoyun An Tetrahydrocannabinoid antigens and method of use
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
US10458963B2 (en) 2016-06-08 2019-10-29 Kathleen Stitzlein Quantitative HPTLC cannabinoid field testing device and method
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
EP4089081B1 (de) * 2020-01-08 2025-07-23 Chengdu Baiyu Pharmaceutical Co., Ltd. Tetrahydrocannabinol-derivat, und herstellungsverfahren dafür und medizinische verwendung davon
WO2021139739A1 (zh) 2020-01-08 2021-07-15 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
CN119534358A (zh) * 2023-08-28 2025-02-28 广州达安基因股份有限公司 Δ9-四氢大麻酚的检测试剂及其制备方法和检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
IL39323A (en) * 1971-05-14 1975-08-31 Syva Co Highly sensitive assay method employing an enzyme for amplification
US4438207A (en) * 1979-09-26 1984-03-20 Hoffmann-La Roche Inc. Radioimmunoassay for cannabinoids
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4652681A (en) * 1982-04-15 1987-03-24 Drug Science Foundation Aminoalkoxy derivatives of propranolol for immunoassay applications
US4650771A (en) * 1983-11-04 1987-03-17 Miles Laboratories, Inc. Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof

Also Published As

Publication number Publication date
AU614733B2 (en) 1991-09-12
DK37888A (da) 1988-07-28
DE3885911T2 (de) 1994-03-24
ATE97895T1 (de) 1993-12-15
FI880332A7 (fi) 1988-07-28
DK37888D0 (da) 1988-01-26
JPS63192770A (ja) 1988-08-10
AU1111588A (en) 1988-07-28
HK63595A (en) 1995-05-05
FI96685C (fi) 1996-08-12
NO171274C (no) 1993-02-17
EP0276732B1 (de) 1993-12-01
JPH0819117B2 (ja) 1996-02-28
FI880332A0 (fi) 1988-01-26
NO880330D0 (no) 1988-01-26
FI96685B (fi) 1996-04-30
EP0276732A3 (en) 1989-02-22
DE3885911D1 (de) 1994-01-13
NZ223289A (en) 1989-06-28
EP0276732A2 (de) 1988-08-03
NO880330L (no) 1988-07-28
NO171274B (no) 1992-11-09
US4833073A (en) 1989-05-23

Similar Documents

Publication Publication Date Title
ES2060610T3 (es) Nuevos derivados del cannabinol e inmunoensayo perfeccionado.
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
ES2061452T3 (es) Nuevas hetrazepinas y procedimiento para su preparacion.
BR0107807A (pt) Derivados de 1,3-dihidro-2h-indol-2-ona, processo para seu preparo e as composições farmacêuticas que os contêm
PT99445A (pt) Processo para preparacao de derivados do 1,4,7,10-tetraazaciclododecano mono-n--substituidos e de composicoes farmaceuticas que os contem
PT96394A (pt) Processo para a preparacao de novos derivados do acido a-nor-esteroide-3-carboxilico e de composicoes farmaceuticas que os contem
ES541870A0 (es) Un procedimiento para preparar un dispositivo de ensayo para determinar la presencia de leucocitos, esterasa o proteasa en una muestra.
SE8302693L (sv) Heterocykliska foreningar
DE69912279D1 (de) 5-ht1f agonisten
EP0712389A4 (de) Therapeutische verbindung-fettsäure-konjugate
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
KR900011754A (ko) (디-3급-부틸히드록시페닐)티오 유도체
ES541871A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrol.
ES2148617T3 (es) Reactivos perfeccionados para un inmunoensayo de cannabinoides.
PT89118A (pt) Processo para a preparacao de derivados de anilina e de composicoes farmaceuticas que os contem
ES521086A0 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
CO5011061A1 (es) Inhibicion de las metaloprotesas de matriz por acidos biariloxobutiricos sustituidos y composiciones farmaceuticas que los contienen
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
BR8900834A (pt) 1,2,4-triazinodionas substituidas e processo para sua preparacao;compostos intermediarios para as mesmas e processos para sua preparacao;composicoes contra protozoarios parasitarios;processo para o combate dos mesmos;e processo para preparacao de composicoes contra protozoarios parasitarios
ES2045768T3 (es) Composiciones topicas que contienen defibrotida.
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
PT97286A (pt) Processo para a preparacao de novos derivados do 3-aminocromano e de composicoes farmaceuticas que os contem
ES2061478T3 (es) Derivados de teofilin-metil-ditiolano y teofilin-metil-ditianilo, un metodo para su preparacion, y composiciones farmaceuticas que los contienen.
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
PT91362A (pt) Processo para a preparacao de novos acidos 6-fluor-3,5-di-hidroxi-carboxilicos e seus derivados, e de composicoes farmaceuticas que os contem e de produtos intermediarios

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 276732

Country of ref document: ES